Cargando…
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
BACKGROUND: The positive transcription elongation factor b (P-TEFb) kinase activity is involved in the process of transcription. Cyclin-dependent kinase 9 (CDK9), a core component of P-TEFb, regulates the process of transcription elongation, which is associated with differentiation and apoptosis in...
Autores principales: | Qing, Yingjie, Wang, Xiangyuan, Wang, Hongzheng, Hu, Po, Li, Hui, Yu, Xiaoxuan, Zhu, Mengyuan, Wang, Zhanyu, Zhu, Yu, Xu, Jingyan, Guo, Qinglong, Hui, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351106/ https://www.ncbi.nlm.nih.gov/pubmed/34372855 http://dx.doi.org/10.1186/s12964-021-00764-5 |
Ejemplares similares
-
Natural HDAC‐1/8 inhibitor baicalein exerts therapeutic effect in CBF‐AML
por: Yu, Xiaoxuan, et al.
Publicado: (2020) -
One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence
por: Qing, Yingjie, et al.
Publicado: (2021) -
Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218
por: Hu, Po, et al.
Publicado: (2021) -
Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies
por: Qing, Yingjie, et al.
Publicado: (2023) -
FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation
por: Hu, Po, et al.
Publicado: (2021)